These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1350659)

  • 1. Seroprevalence of HTLV-I and HTLV-II.
    Zanetti AR; Galli C
    N Engl J Med; 1992 Jun; 326(26):1783; author reply 1783-4. PubMed ID: 1350659
    [No Abstract]   [Full Text] [Related]  

  • 2. Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients.
    Hernandez Ramirez P; Rivero Jimenez R; Ballester Santovenia M; Navea Leyva L; Matutes E; Catovsky D; Yamaguchi K; Fukuyoshi Y; Nishimura Y; Kiyokawa T
    Vox Sang; 1991; 61(4):277-8. PubMed ID: 1685604
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of markers for HTLV infection among australian injecting drug users.
    Crofts N; Silvester C; Ross M
    Med J Aust; 1992 Jul; 157(1):70-1. PubMed ID: 1353605
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell lymphotropic virus infection in pregnant women in Spain.
    Tuset C; Gutiérrez M; Carbonell C; Tuset T; Soriano V
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):771-3. PubMed ID: 9405953
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation, sequencing and ultrastructure of HTLV-I and HTLV-II retroviruses. Presence of the HTLV-II subtype b among Spanish intravenous drug addicts].
    Vallejo A; Casado C; Cantó C; Varela JM; Barge T; Rabella N; Herrera I; García Sáiz A
    Med Clin (Barc); 1994 Dec; 103(19):730-6. PubMed ID: 7799679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients.
    Manca N; Graifenberghi S; Colombrita D
    Eur J Epidemiol; 1990 Jun; 6(2):201-6. PubMed ID: 1972926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
    Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
    Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
    [No Abstract]   [Full Text] [Related]  

  • 9. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of HTLV-I and HTLV-II.
    LaBrie RA; McAuliffe WE; Nemeth-Coslett R
    N Engl J Med; 1992 Jun; 326(26):1783; author reply 1783-4. PubMed ID: 1350658
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to human T-lymphotropic virus type I/II (HTLV-I/II) among male inmates entering Maryland prisons.
    Vlahov D; Lee H; Taylor E; Canavaggio M; Canner C; Burczak J; Saah AJ
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):531-5. PubMed ID: 1969961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection.
    Varnier OE; Lillo F; Alexander SS; Forbis RM; Present W; Lazzarin A
    JAMA; 1991 Feb; 265(5):597. PubMed ID: 1987408
    [No Abstract]   [Full Text] [Related]  

  • 13. Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate western blot pattern.
    Tuppin P; Makuwa M; Guerma T; Bazabana MM; Loukaka JC; Jeannel D; M'Pelé P; de Thé G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):105-7. PubMed ID: 8528728
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of HIV and HTLV in a representative sample of the Spanish population.
    Castilla J; Pachón I; González MP; Amela C; Muñoz L; Tello O; Noguer I; de Ory F; León P; Alonso M; Gil E; García-Sáiz A
    Epidemiol Infect; 2000 Aug; 125(1):159-62. PubMed ID: 11057971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the South Bronx, New York.
    Factor SH; Irwin KL; Lal RB; Rudolph D; Weber TJ; Olivo N; Ernst J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):97-7. PubMed ID: 8624769
    [No Abstract]   [Full Text] [Related]  

  • 16. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of HTLV-related proviral DNA sequences and antibodies reactive with HTLV internal proteins in an Hungarian patient with Sézary syndrome.
    Kiss J; Kiss A; Tóth FD; Surányi P; Szegedi A; Rak K
    Leuk Lymphoma; 1992 Aug; 7(5-6):511-5. PubMed ID: 1362917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.